Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Leuk Lymphoma. 2019 Jan 10;60(9):2278–2282. doi: 10.1080/10428194.2018.1563294

Table 2.

Identified Secondary Malignancies

Malignancy FDG-PET CT BMB
DLBCL (n=5) 5 4 1
Thyroid Cancer (n=3) 3 2 0
NSCLC (n=1) 1 0 0
Peripheral Nerve Sheath Tumor (n=1) 1 1 0
Isolated Bone Marrow Low Grade B Cell Lymphoma (n=14) 2 0 14